Gulam Abbas Manji (@DrGManji) header
Gulam Abbas Manji (@DrGManji) profile picture

Husband & Father. Physician Scientist, MD, PhD, Director of Pancreas Medical Oncology, Director of GI Medical Oncology @ColumbiaMed

New York, USA
Joined May 2022
Photo by Gulam Abbas Manji (@DrGManji)Photo by Gulam Abbas Manji (@DrGManji)
Gulam Abbas Manji retweeted
Truly an honor to give the #Keynote Lecture @columbiacancer on Targeting #KRAS in #PancreaticCancer: G12C, RASON, GDP inhibitors, PROTAC, vaccines and much more!!! 🙏🙏 @DrGManji and faculty for the kind invite and congratulations on a fantastic symposium!!!
2
7
37
5,836
Happy to report that our trial in gastric cancer published in JAMAOnc. Privileged to have worked with ⁦@mdmanishshah⁩, ⁦@ParkHaesong⁩, and AlexRaufi. Thanks to all the patients who participated in the study.
1
3
1
19
1,939
Proud to report the results of the pilot phase of our investigator-initiated clinical trial @AACR Pancreas. I started the preclinical study in KPC mice in @KenOliveLab and then work continued in my lab. Randomized phase 2 to activate soon at 5 sites!
3
6
1
41
2,877
On the latest episode of Columbia Conversations & Curbsides, Dr. Gulam Manji (@DrGManji) sits down to share updates on the current state of pancreatic cancer care. @ColumbiaSurgery Listen here: open.spotify.com/episode/7ma…
2
9
Thank you for the discussion, @hyesooLoweMD. It brings much needed attention to pancreatic cancer and highlights the need for more patients to enroll in clinical trials. #PanCan
1
6
Gulam Abbas Manji retweeted
Comprehensive discussion by @LizzySmyth1 of the phase II trial by Dr. Gulam Manji et al➡️ peri-operative chemotherapy/pembrolizumab in resectable gastric/OGJ adenoca followed by adjuvant pembro. Proof of principle of increased RR; phase 3 data awaited @AACR #AACR22.
1
15
1
30
Thanks @KenOliveLab for the warm welcome to Twitter! Finally joining in to highlight the great work being done in GI immuno-oncology
Everybody welcome to Twitter former OliveLab trainee @DrGManji, now leading our pancreas med/onc program @columbiacancer @PancreasCenter and leading a research program in pancreatic cancer immuno-oncology. Amazing clinical trialist and cancer researcher! #scitwitter
3